Employers group Ibec has today appointed two new directors for its BioPharmaChem and Irish Medtech associations.
Sinead Keogh has been appointed Director of BioPharmaChem Ireland, the Ibec group that represents the biopharma and chemical sectors
Eoghan Ó Faoláin has been appointed Director of the Irish Medtech Association, the Ibec group representing the medical technology sector.
The biopharma, medtech, and digital health sectors span more than 700 companies and employ 102,000 people directly, They make a global impact with exports in excess of €120 billion, Ibec said.
Ibec has brought together these industries to enable Ireland to become a recognised global hub for digital health by increasing awareness and advocating for policies that make an impact under the "Where Digital Health Thrives" campaign.
Sinead Keogh is transitioning from her current role as Director of Ibec Medtech and Engineering but will continue her Strategic Business Lead role as Ibec Head of Sectors while taking up the new role as Director of BioPharmaChem Ireland (BPCI).
With over 18 years of experience in Ibec, Sinead recently joined the Industry Advisory Board for SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, having previously sat on the Industry Advisory Board for BioInnovate Ireland from 2013-2023, and the Governance Board for Science Foundation Ireland funded Irish Photonic Integration Centre (IPIC) for three years.
Before joining Ibec, Sinead held technical roles at 3Com Technologies and lectured part-time at DIT, Kevin Street.
Eoghan Ó Faoláin will lead the Irish Medtech Association, which has more than 250 members located throughout the island of Ireland.
He has over 15 years of experience with Ibec, having been appointed Deputy Director of the Irish Medtech Association in 2022, and previously served as the Technology Ireland Acting Director.
Before that he was Head of Public Sector at Ibec, supporting Ibec's voluntary hospitals, further and higher education organizations, and public sector bodies.
